FDA Investigator: Gavin T. Cua

- Gavin T. Cua first started conducting FDA inspections in 2020, with the last inspection in 2024. Over that time, Gavin T. Cua has conducted 30 inspections at 29 companies across 29 sites.

Get Gavin Cua's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Beibei | 2024

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Chongqing Huapont Shengchem Pharmaceutical Co Ltd, Hechuan | 2024

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Chongqing Benji Biotechnology Co., Ltd., Chongqing | 2024

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Natures Formulae Health Products Ltd., Kelowna | 2023

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Tayca Corporation, Okayama | 2023

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Apex Healthcare Limited, Ankleshwar | 2023

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 PAB Organics Private Limited, Vadodara | 2023

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Transfer Technology, Inc., Huntington Beach | 2023

Out-of-stock
Gavin T. Cua
Human Drugs Form 483

FDA 483 Isotopia Molecular Imaging Ltd (Soreq Site), Yavne | 2022

Out-of-stock
Gavin T. Cua
Human Drugs Form 483